BeOne Medicines Ltd. American Depositary Shares (ONC) is a publicly traded Healthcare sector company. As of May 21, 2026, ONC trades at $309.42 with a market cap of $30.41B and a P/E ratio of 853.25. ONC moved +3.95% today. Year to date, ONC is -3.61%; over the trailing twelve months it is +30.35%. Its 52-week range spans $172.67 to $385.22. Analyst consensus is strong buy with an average price target of $388.58. Rallies surfaces ONC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BeOne Medicines jumps on Q1 beat, higher 2026 outlook and BRUKINSA momentum: BeOne Medicines (ONC) rose after reporting first-quarter 2026 revenue of $1.51 billion, up 35% year over year, and GAAP EPS of $1.96. Investors also reacted to $1.1 billion in BRUKINSA revenue (+38%) and a raised 2026 outlook alongside pipeline updates ahead of major oncology presentations.
| Metric | Value |
|---|---|
| Price | $309.42 |
| Market Cap | $30.41B |
| P/E Ratio | 853.25 |
| EPS | $0.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $385.22 |
| 52-Week Low | $172.67 |
| Volume | 6.54K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.74B |
| Net Income | $513.02M |
| Gross Margin | 88.31% |
12 analysts cover ONC: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $388.58.